Targeted Nano-formulations for Treatment of MRSA: A multicomponent platform for nano-formulated treatment of resistant microbial infections

Informazioni relative al progetto

LeadtoTreat

ID dell’accordo di sovvenzione: 101046941

DOI 10.3030/101046941

Data della firma CE 16 Marzo 2022

Data di avvio 1 Marzo 2022

Data di completamento 28 Febbraio 2026

Finanziato da

• The European Innovation Council (EIC)

Costo totale € 2 665 565,00

Contributo UE € 2 665 564,75

Coordinato da

SINTEF AS
Norway

Risultati finali

Websites, patent fillings, videos etc. (1)

Public website and communication toolkit

Public website and communication toolkit prepared including design of logo

Documents, reports (2)

Updated Data Management Plan after RP1

Updated Data Management Plan after first reporting period

Data Management Plan

First version of the Data Management Plan